Overview

Drug Discovery Services Market is estimated to value over USD 19 billion by 2028 end and register a CAGR of over 10% during the forecast period 2021 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Discovery Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Drug Discovery Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Key market players involved in the Drug Discovery Services Market are:
• Thermo Fisher Scientific
• Merck
• GE Healthcare
• Albany Molecular Research, Inc (AMRI)
• Charles River Laboratories International
• Evotec
• Pharmaceutical Product Development, LLC. (Ppd)
• Jubilant Biosys
• Covance
• Genscript Biotech Corporation
• Aurigene Discovery Technologies
• Wuxi Apptec
• Syngene
• Eurofins Scientific
• GVK Biosciences Private Limited
• Laboratory Corporation of America Holdings
• Lonza Group AG
• Piramal Enterprises Ltd
• Viva Biotech
• Dalton Pharma Services
• Domainex
• Selvita S.A.
• SRI International
• BioDuro

Drug Discovery Services Market Segmentation:
By Process
• Target Selection
• Target Validation
• Hit-to-Lead Identification
• Lead Optimization
• Candidate Validation
By Type
• Medicinal Chemistry
• Biology Services
• Drug Metabolism and Pharmacokinetics
By Drug Type
• Small Molecules
• Biologics
By Therapeutic Area
• Oncology
• Neurology
• Cardiovascular Diseases
• Respiratory Diseases
• Diabetes
• Other Therapeutics Areas
By Company Type
• Tier 1 Pharmaceutical Companies
• Tier 2 Pharmaceutical Companies
• Tier 3 Pharmaceutical Companies
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the drug discovery services market  By Process, By Type, By Drug Type, By Therapeutic Area, By Company Type and By Region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Global Drug Discovery Services Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Drug Discovery Services Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Drug Discovery Services Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Global Drug Discovery Services Market, By Process Historical Analysis and Forecast 2021-2028 (USD Million)
   7.1. Target Selection
   7.2. Target Validation
   7.3. Hit-to-Lead Identification
   7.4. Lead Optimization
   7.5. Candidate Validation

8. Global Drug Discovery Services Market, By Type Historical Analysis and Forecast 2021-2028 (USD Million)  
   8.1. Medicinal Chemistry
   8.2. Biology Services
   8.3. Drug Metabolism and Pharmacokinetics

9. Global Drug Discovery Services Market, By Drug Type Historical Analysis and Forecast 2021-2028 (USD Million)  
   9.1. Small Molecules
   9.2. Biologics

10. Global Drug Discovery Services Market, By Therapeutic Area Historical Analysis and Forecast 2021-2028 (USD Million)  
    10.1. Oncology
    10.2. Neurology
    10.3. Cardiovascular Diseases
    10.4. Respiratory Diseases
    10.5. Diabetes
    10.6. Other Therapeutics Areas

11. Global Drug Discovery Services Market, By Company Type Historical Analysis and Forecast 2021-2028 (USD Million)  
    11.1. Tier 1 Pharmaceutical Companies
    11.2. Tier 2 Pharmaceutical Companies
    11.3. Tier 3 Pharmaceutical Companies

12. North America Drug Discovery Services Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. U.S.A
          12.2.2. Canada
          12.2.3. Mexico
    12.3. Market Size (USD Million) Forecast for North America 2021-2028

13. Latin America Drug Discovery Services Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Brazil
          13.2.2. Venezuela
          13.2.3. Argentina
          13.2.4. Rest of Latin America
    13.3. Market Size (USD Million) Forecast for Latin America 2021-2028

14. Europe Drug Discovery Services Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. Germany
          14.2.2. U.K         
          14.2.3. France
          14.2.4. Italy
          14.2.5. Spain
          14.2.6. Russia
          14.2.7. Poland
          14.2.8. Rest of Europe
    14.3. Market Size (USD Million) Forecast for Europe 2021-2028

15. Asia Pacific Drug Discovery Services Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          15.2.1. Japan
          15.2.2. China
          15.2.3. India
          15.2.4. Australia and New Zealand
          15.2.5. ASEAN
          15.2.6. Rest of Asia Pacific
    15.3. Market Size (USD Million) Forecast for Asia Pacific 2021-2028  

16. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          16.2.1. Saudi Arabia
          16.2.2. UAE
          16.2.3. South Africa
          16.2.4. Egypt
    16.3. Market Size (USD Million) Forecast for MEA 2021-2028

17. Market Share Analysis and Competitive Landscape   
    17.1. Global Landscape - Key Players, Revenue and Presence
    17.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    17.3. Global Emerging Companies
    17.4. North America - Market Share Analysis and Key Regional Players
    17.5. Europe - Market Share Analysis and Key Regional Players
    17.6. Asia Pacific - Market Share Analysis and Key Regional Players
    17.7. Global Key Player - Growth Matrix

18. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    18.1. Thermo Fisher Scientific
          18.1.1. Company Overview
          18.1.2. Product Portfolio
          18.1.3. SWOT Analysis
          18.1.4. Financial Overview
          18.1.5. Strategic Overview
    18.2. Merck
          18.2.1. Company Overview
          18.2.2. Product Portfolio
          18.2.3. SWOT Analysis
          18.2.4. Financial Overview
          18.2.5. Strategic Overview 
    18.3. GE Healthcare
          18.3.1. Company Overview
          18.3.2. Product Portfolio
          18.3.3. SWOT Analysis
          18.3.4. Financial Overview
          18.3.5. Strategic Overview
    18.4. Albany Molecular Research, Inc. (AMRI)
          18.4.1. Company Overview
          18.4.2. Product Portfolio
          18.4.3. SWOT Analysis
          18.4.4. Financial Overview
          18.4.5. Strategic Overview
    18.5. Pharmaceutical Product Development, LLC. (Ppd)
          18.5.1. Company Overview
          18.5.2. Product Portfolio
          18.5.3. SWOT Analysis
          18.5.4. Financial Overview
          18.5.5. Strategic Overview          
    18.6. Jubilant Biosys
          18.6.1. Company Overview
          18.6.2. Product Portfolio
          18.6.3. SWOT Analysis
          18.6.4. Financial Overview
          18.6.5. Strategic Overview
    18.7. Covance
          18.7.1. Company Overview
          18.7.2. Product Portfolio
          18.7.3. SWOT Analysis
          18.7.4. Financial Overview
          18.7.5. Strategic Overview
    18.8. Genscript Biotech Corporation
          18.8.1. Company Overview
          18.8.2. Product Portfolio
          18.8.3. SWOT Analysis
          18.8.4. Financial Overview
          18.8.5. Strategic Overview
    18.9. Aurigene Discovery Technologies
          18.9.1. Company Overview
          18.9.2. Product Portfolio
          18.9.3. SWOT Analysis
          18.9.4. Financial Overview
          18.9.5. Strategic Overview          
    18.10.Wuxi Apptec
          18.10.1. Company Overview
          18.10.2. Product Portfolio
          18.10.3. SWOT Analysis
          18.10.4. Financial Overview
          18.10.5. Strategic Overview
    18.11.Syngene
          18.11.1. Company Overview
          18.11.2. Product Portfolio
          18.11.3. SWOT Analysis
          18.11.4. Financial Overview
          18.11.5. Strategic Overview
    18.12.Eurofins Scientific
          18.12.1. Company Overview
          18.12.2. Product Portfolio
          18.12.3. SWOT Analysis
          18.12.4. Financial Overview
          18.12.5. Strategic Overview
    18.13.GVK Biosciences Private Limited
          18.13.1. Company Overview
          18.13.2. Product Portfolio
          18.13.3. SWOT Analysis
          18.13.4. Financial Overview
          18.13.5. Strategic Overview
    18.14.Laboratory Corporation of America Holdings
          18.14.1. Company Overview
          18.14.2. Product Portfolio
          18.14.3. SWOT Analysis
          18.14.4. Financial Overview
          18.14.5. Strategic Overview
    18.15.Lonza Group AG
          18.15.1. Company Overview
          18.15.2. Product Portfolio
          18.15.3. SWOT Analysis
          18.15.4. Financial Overview
          18.15.5. Strategic Overview
    18.16.Piramal Enterprises Ltd.
          18.16.1. Company Overview
          18.16.2. Product Portfolio
          18.16.3. SWOT Analysis
          18.16.4. Financial Overview
          18.16.5. Strategic Overview
    18.17.Viva Biotech
          18.17.1. Company Overview
          18.17.2. Product Portfolio
          18.17.3. SWOT Analysis
          18.17.4. Financial Overview
          18.17.5. Strategic Overview
    18.18.Dalton Pharma Services
          18.18.1. Company Overview
          18.18.2. Product Portfolio
          18.18.3. SWOT Analysis
          18.18.4. Financial Overview
          18.18.5. Strategic Overview
    18.19.Domainex
          18.19.1. Company Overview
          18.19.2. Product Portfolio
          18.19.3. SWOT Analysis
          18.19.4. Financial Overview
          18.19.5. Strategic Overview
    18.20.Selvita S.A.
          18.20.1. Company Overview
          18.20.2. Product Portfolio
          18.20.3. SWOT Analysis
          18.20.4. Financial Overview
          18.20.5. Strategic Overview
    18.21.SRI International
          18.21.1. Company Overview
          18.21.2. Product Portfolio
          18.21.3. SWOT Analysis
          18.21.4. Financial Overview
          18.21.5. Strategic Overview
    18.22.BioDuro
          18.22.1. Company Overview
          18.22.2. Product Portfolio
          18.22.3. SWOT Analysis
          18.22.4. Financial Overview
          18.22.5. Strategic Overview

19. Pre and Post COVID-19 Impact
    19.1. Positive influence on the healthcare industry
    19.2. The financial disruption of the manufacturing sector
    19.3. Impact of COVID-19 on emerging companies
    19.4. Significant mandates in the healthcare regulations initiated by administrations
    19.5. The overall economic slowdown of the developing and developed nations

20. FutureWise SME Key Takeaway Points for Client

Tables

Figures